Lataa...
Systemic mesenchymal stem cells reduce growth rate of cisplatin-resistant ovarian cancer
Epithelial ovarian cancer is one of the most malignant cancers in women and resistant to chemotherapy is the major obstacle for the five-year survival rate. Cisplatin is one of the effective anticancer drug used in the ovarian cancer. To find a good strategy to cure the tumors which is resistant to...
Tallennettuna:
| Päätekijät: | , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
e-Century Publishing Corporation
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3816820/ https://ncbi.nlm.nih.gov/pubmed/24228113 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|